Navigation Links
Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
Date:3/17/2008

MOUNTAIN VIEW, Calif., March 17 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) reported today financial results for its fourth quarter and year ended December 31, 2007, and provided an update on the Company's progress with its six clinical-stage development programs.

"During 2007 and the first quarter of 2008, we moved all of our clinical programs forward. This year is an important transitional year for Alexza, as we initiate the Phase 3 clinical trials of our lead program, AZ-004 (Staccato(R) loxapine)," said Thomas B. King, Alexza President and CEO. "In addition, we are beginning the initial AZ-004 commercial planning for manufacturing, regulatory submissions, and potential sales and marketing. It is also important to note that we have five additional product candidates in various stages of clinical development in four different therapeutic areas. With our own programs, and with our partnerships with Endo Pharmaceuticals and Symphony Allegro, we look forward to solid progress in these development programs during 2008."

Product Candidate Development and Corporate Goals Update

-- AZ-004 (Staccato loxapine) is initially being developed for the treatment of acute agitation in patients with schizophrenia or bipolar disorder. In February 2008, the Company initiated a Phase 3 clinical trial that is designed to enroll approximately 300 schizophrenic patients with acute agitation at 25 U.S. clinical centers. The trial is an in-clinic, multi- center, randomized, double-blind, placebo-controlled study and will test AZ- 004 at two dose levels (5 and 10 mg). Patients may receive up to 3 doses of study drug in a 24-hour period, depending on their clinical status. The primary endpoint for the study is the re
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... April 25, 2015  With the introduction of Elekta,s ... cranial radiosurgery are now available for more patients with ... latest generation stereotactic radiosurgery system for the brain, integrates ... increasing the versatility of Gamma Knife radiosurgery. Elekta unveiled ... ESTRO Forum in Barcelona . ...
(Date:4/24/2015)... , April 24, 2015   Bernstein ... Pharmaceuticals, Inc. ("Aerie" or the "Company") (NASDAQ: ... to investors in violation of the federal securities ... Aerie breached their fiduciary duties to shareholders. ... on the discovery, development and commercialization of first-in-class ...
(Date:4/24/2015)... -- Bayer Corporation hosted its annual "Take Your Child to Work ... headquarters.  This is Bayer,s second "Take Your Child To Work ... campus, and Thursday,s event welcomed 230 children ready to see ... Fortunately, for the kids, this was not just another ... "Science For A Better Life," Bayer made sure that "Take ...
Breaking Medicine Technology:New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc. 2Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4
... VIEW, Calif., Dec. 21, 2010 MAP Pharmaceuticals, Inc. (Nasdaq: ... ™ open-label safety trial.  The Company has now completed ... (NDA) for LEVADEX and plans to submit an NDA in ... inhaled migraine therapy that has completed Phase 3 clinical development ...
... -- China Botanic Pharmaceutical Inc. (AMEX: CBP ... and distributor of botanical products, bio-pharmaceuticals and traditional Chinese ... considerable progress in its efforts to comply with the ... 404") for fiscal year 2010. As announced ...
Cached Medicine Technology:MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial 2MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial 3China Botanic Announces Progress on its SOX 404 Compliance Program 2China Botanic Announces Progress on its SOX 404 Compliance Program 3
(Date:4/26/2015)... Italian public health researchers have released ... cement plants and other asbestos-related industries. Surviving Mesothelioma has ... Click here to read it now. , ... and Environmental Medicine analyzed more than 15,000 cases of ... where the asbestos cancer was most common. , ...
(Date:4/26/2015)... Aliso Viejo, CA (PRWEB) April 26, 2015 ... Final Cut Pro X editors can quickly and ... a Lookup Table that contains a mathematical formula for modifying ... corresponding color indicated by the table. This pack comes with ... was inspired by vintage and contemporary black and white films. ...
(Date:4/26/2015)... 2015 India Network Foundation, a non-profit ... community services to the Asian Indian community in the ... for more than two decades. The India News Network ... subscribers around the world with the latest news items ... The Immigration Law Forum Digest, edited and contributed by ...
(Date:4/26/2015)... April 26, 2015 Forbes Living ... city is one which is synonymous with clean beaches, sparkling ... and education are major economic influencers in the city on ... dynamic talk show are pleased to announce the show will ... 26 at 3:00 PM PDT. Tune in to find out ...
(Date:4/25/2015)... (PRWEB) April 26, 2015 The ... (ACE.S) , a national endeavor to prepare nurses to ... is a great success, according to a new report ... program's original funding partners. , The project began ... Philadelphia (CCP), under the direction of Elaine Tagliareni, EdD, ...
Breaking Medicine News(10 mins):Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 3Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3
... WallSt.net,s 3-Minute,Press Show is a daily video ... Shows air Monday through Friday on:, http://www.wallst.net/wallst_tv/3_minute_press_show/index.php ., ... with,public company executives on their company and most ... viewers with insight into a company,s most,recent press ...
... Affiliated Computer,Services, Inc. (NYSE: ACS ) ... to provide business process outsourcing (BPO), information,technology outsourcing ... for Affordable Quality Healthcare. The multi-million dollar deal,has ... one-year options, including a,six-month implementation period., CAQH ...
... VANCOUVER, Wash., March 19 What happens when you ... and you continually,see critical needs that are not being ... a local 501(c)(3) non-profit,agency, has dared to ask, and ... result is the CDM Community Partnership Initiative (CPI), a,three-year ...
... 19 The following was,released today by Dr. Agarwal Hospital:, ... form human DNA. The,scientific community world wide had thought we ... surgeon has made the first breakthrough,in the making of DNA ... last 4,years. Dr. Sunita Rana Agarwal attributes the Science of ...
... fossil hunter and anatomy professor Kenneth Rose, Ph.D. was displaying ... seminar at the Johns Hopkins University School of Medicine when ... , That unanticipated eureka moment has led researchers at the ... rabbits. The fossil evidence in hand, found in west-central India, ...
... up an estimated 10 to 13 percent of the American ... States in 2007 was $70.5 billion, with estimates for 2008 ... entries into the United States of imported food and food-related ... points which include ports, border crossings, and postal facilities. ...
Cached Medicine News:Health News:Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: INIX, BPAX, GLOW, LB 2Health News:Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: INIX, BPAX, GLOW, LB 3Health News:Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: INIX, BPAX, GLOW, LB 4Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 2Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 3Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 4Health News:Local Non Profit Provides Solutions for Elderly and Disabled 2Health News:Local Non Profit Provides Solutions for Elderly and Disabled 3Health News:Science of Sri Vidya Benefits DNA Genesis, Says Dr. Sunita Rana Agarwal 2Health News:Good luck indeed: 53 million-year-old rabbit's foot bones found 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: